Botulinum Neurotoxin Light Chains Expressed by Defective Herpes Simplex Virus Type-1 Vectors Cleave SNARE Proteins and Inhibit CGRP Release in Rat Sensory Neurons

Light Chain Diversity among the Botulinum Neurotoxins

(2018) Alexander Gardner et al.   Toxins

The Expanding Therapeutic Utility of Botulinum Neurotoxins

(2018) Elena Fonfria et al.   Toxins

Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity

(2017) Charles Joussain et al.   NEUROUROLOGY AND URODYNAMICS

Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology

(2017) Marco Pirazzini et al.   PHARMACOLOGICAL REVIEWS

Botulinum toxin in the management of chronic migraine: clinical evidence and experience

(2016) Claus M Escher et al.   Therapeutic Advances in Neurological Disorders

Targeted Oncolytic Herpes Simplex Virus Type 1 Eradicates Experimental Pancreatic Tumors

(2015) Marion Gayral et al.   HUMAN GENE THERAPY

Dual-Use Research of Concern (DURC) Review at American Society for Microbiology Journals: FIG 1 

(2015) Arturo Casadevall et al.   mBio

Long-term outcomes of balloon dilation versus botulinum toxin injection in patients with primary achalasia

(2014) Ho Eun Jung et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

(2012) Victor W. Nitti et al.   JOURNAL OF UROLOGY

Gene therapy for pain: Results of a phase I clinical trial

(2011) David J. Fink et al.   ANNALS OF NEUROLOGY

Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial

(2011) Francisco Cruz et al.   EUROPEAN UROLOGY

Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-A randomized trial

(2011) Joseph Jankovic et al.   MOVEMENT DISORDERS

Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors

(2010) Pelagia Foka et al.   JOURNAL OF GENE MEDICINE

Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm

(2010) Bettina Wabbels et al.   JOURNAL OF NEURAL TRANSMISSION

N-Methyl-d-aspartate receptors are required for synaptic targeting of Alzheimer’s toxic amyloid-β peptide oligomers

(2010) Helena Decker et al.   JOURNAL OF NEUROCHEMISTRY

Refractory Idiopathic Urge Urinary Incontinence and Botulinum A Injection

(2008) Linda Brubaker et al.   JOURNAL OF UROLOGY